Professor Hugh Gallagher

Hugh Gallagher is a Consultant Nephrologist practising at the South West Thames Renal Unit St Helier Hospital, Nuffield Health Parkside Hospital in Wimbledon, the Guildford Nuffield Hospital and the Surrey Cardiovascular Clinic.

He was appointed as a Consultant Nephrologist at Epsom and St Helier NHS Trust in 2004 and was awarded visiting Professor status at the University of Southampton in 2017. 

His clinical interests include chronic kidney disease (CKD), proteinuria, and cardiovascular disease in chronic kidney disease. He sees adults only.

Professor Gallagher has a longstanding interest in CKD and has contributed to national research and improvement programmes funded by the Health Foundation and the National Institute for Health Research. 

He has worked extensively with NICE (the National Institute for Health and Care Excellence), serving on a large number of NICE guideline development covering chronic kidney disease, renal replacement therapy, gout, diabetes and cardiovascular disease prevention.  He was a Specialist Committee member for the CKD Quality Standard and has contributed the NICE Technology Appraisal programme.  

He previously co-authored a successful application for a National Clinical Audit of CKD management in Primary Care, and a successful bid for CKD to be a Clinical Priority area for the Royal College of GPs for 2013-2016.

Hugh was a member of the work group that developed a National Renal Reserch Strategy. He led the ASSIST-CKD trial which explore the use of graphical surveillance to reduce late presentation for dialysis.   He is co-Chief Investigator of the ATTACK trial on aspirin for primary prevention of cardiovascular disease in people with CKD.